TY  - CONF 
AU  - López López, Rafael
PY  - 2015
SN  - 095-9804
UR  - http://hdl.handle.net/20.500.11940/3737
LA  - eng
TI  - Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The
VL  - 51
ER  -